Key Highlights
- On April 20, BWX Technologies disclosed its strategic agreement to purchase Precision Components Group (PCG), a domestic producer specializing in sophisticated heavy-walled and heat-transfer manufacturing.
- This transaction incorporates more than 500,000 square feet of domestic heavy-manufacturing infrastructure and over 400 skilled workers into BWXT’s operations.
- PCG recorded approximately $125 million in annual revenue and will be integrated into BWXT’s Commercial Operations division.
- BWXT exceeded fourth-quarter projections, delivering EPS of $1.08 compared to the $0.91 forecast, alongside revenue of $885.8M versus anticipated $837.5M, establishing FY2026 guidance between $4.55–$4.70 EPS.
- Approximately 94.39% of shares are held by institutional investors, with Alkeon and Invesco making substantial recent purchases, while company insiders divested roughly 13,327 shares totaling $2.73M during the past three months.
BWX Technologies (NYSE: BWXT) is executing a strategic expansion of its commercial nuclear operations through the anticipated acquisition of Precision Components Group.
The transaction, unveiled on April 20, will integrate PCG along with its subsidiary operations — Precision Custom Components and DC Fabricators — into BWXT’s organizational structure. PCG will operate within BWXT’s Commercial Operations division while maintaining operations at its current locations.
According to BWXT, this acquisition delivers over 500,000 square feet of domestic heavy-manufacturing infrastructure. The deal also incorporates a team exceeding 400 experienced professionals.
PCG achieved approximately $125 million in annual revenue during the previous fiscal year, representing a significant addition to BWXT’s revenue stream. Company leadership characterizes this acquisition as an initial phase in establishing robust US-based commercial nuclear manufacturing capabilities.
According to John MacQuarrie, President of Commercial Operations at BWXT, the transaction “builds on BWXT’s strong performance in the commercial nuclear industry” and aims to address what he described as “the accelerating needs of US commercial nuclear customers.”
Robust Financial Performance Supports Strategic Move
BWXT entered this transaction from a position of financial strength. The company exceeded Wall Street projections in its latest quarterly report, delivering EPS of $1.08 versus the consensus estimate of $0.91. Revenue reached $885.8 million, surpassing the anticipated $837.5 million.
This revenue represented an 18.7% increase compared to the prior year, and across fiscal year 2025, BWXT achieved 18% total revenue growth reaching $3.19 billion. Earnings per share climbed 20% during this timeframe with a net profit margin of 10.3%.
Looking toward FY2026, management has established EPS guidance ranging from $4.55 to $4.70. Wall Street analysts maintain a collective “Moderate Buy” recommendation on the security with an average price target of $207.60.
BWXT shares began trading at $223.54 on Friday, exceeding both the 50-day moving average of $211.42 and the 200-day moving average of $198.99. The security trades within a 52-week range spanning $102.42 to $241.82 with a market capitalization of $20.48 billion.
The corporation also implemented a modest dividend increase, adjusting the quarterly distribution to $0.27 from $0.25, translating to an annualized rate of $1.08 and a yield of approximately 0.5%.
Continued Institutional Accumulation
Institutional investors control approximately 94.39% of BWXT’s outstanding shares. Multiple major funds expanded their holdings in recent reporting periods. Alkeon Capital Management increased its position by 163% during Q3, now controlling over 1.57 million shares valued at roughly $291 million. Invesco boosted its stake by 60.1% to exceed 2.5 million units.
B. Metzler seel. Sohn & Co. AG established a new position during Q4, acquiring 9,481 shares worth approximately $1.64 million.
Conversely, corporate insiders have been sellers. Company executives divested approximately 13,327 shares totaling $2.73 million during the previous 90-day period. CAO Kevin James Gorman liquidated 1,344 shares in early March at an average price of $214.71. Insider ownership currently represents about 0.60% of outstanding shares.
Regarding analyst coverage, Wells Fargo launched coverage with an “underweight” recommendation and $200 price objective. TD Cowen assigned a “buy” rating with a $230 target. Zacks Research elevated BWXT from “hold” to “strong-buy” during January.
BWXT holds the exclusive position as the manufacturer of naval nuclear reactors for American submarines and aircraft carriers, having constructed over 400 naval reactors beginning with the USS Nautilus.


